KOMAL A TRIVEDI

Allopathic & Osteopathic Physicians|Internal Medicine NOVI, MI NPI 1679736565

General Payments — all program years on this page

$1,906.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 153
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $338.68 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $338.6820

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $115.286
Acerta Pharma LLC $110.487
GlaxoSmithKline, LLC. $52.253
Amgen Inc. $30.282
PFIZER INC. $17.061
Exact Sciences Corporation $13.331

By program year

Program yearAmountRecords
2018 $679.5463
2019 $541.1049
2020 $14.111
2021 $69.224
2022 $39.312
2023 $224.3114
2024 $338.6820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096601115 Novo Nordisk Inc $21.32 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096953776 Novo Nordisk Inc $14.81 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097417108 Novo Nordisk Inc $19.02 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097583807 Novo Nordisk Inc $19.70 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097682902 Novo Nordisk Inc $21.80 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097769110 Novo Nordisk Inc $18.63 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104302560 AstraZeneca Pharmaceuticals LP $17.99 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104331834 AstraZeneca Pharmaceuticals LP $13.99 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104477632 AstraZeneca Pharmaceuticals LP $15.30 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104600612 AstraZeneca Pharmaceuticals LP $13.46 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104634401 AstraZeneca Pharmaceuticals LP $16.52 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105480455 AstraZeneca Pharmaceuticals LP $17.25 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105569205 AstraZeneca Pharmaceuticals LP $15.97 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111727995 Amgen Inc. $13.69 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114935268 Exact Sciences Corporation $13.33 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116234701 GlaxoSmithKline, LLC. $14.37 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116421727 GlaxoSmithKline, LLC. $18.55 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116469130 GlaxoSmithKline, LLC. $19.33 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117402140 Amgen Inc. $16.59 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131729027 PFIZER INC. $17.06 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.